FDA sends warning letter to Philips due to quality issues
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier this year. The letter, dated Sept. 9, highlights nine violations found at the facilities, located in Washington, Pennsylvania and the Netherlands. The FDA urged Philips to investigate and determine the causes of the violations and take swift action to bring impacted products into compliance.
Related News Articles
Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…
Headline
The Food and Drug Administration has issued an early alert for all automated Impella controllers by Abiomed following an issue that has caused three deaths and…
Headline
Boston Scientific, a large supplier of medical devices, said in an Aug. 26 statement posted on its website that on Aug. 25 it “identified a cybersecurity…
Headline
In this conversation, Caroline DeLongchamps, director of the patient- and family-centered care program at MUSC Health, shares a powerful personal story and…
Headline
The AHA Aug. 11 published a new issue brief on how hospitals and health systems can incorporate care navigation and coordination into their patient care…
Blog
In our previous blog, we examined what the AHA’s affordability recommendations could mean for patients. Now we turn to another critical stakeholder group:…